Ovarian Endometrioid Adenocarcinoma Arising from an Endometriotic Cyst in a Postmenopausal Woman under Tamoxifen Therapy for Breast Cancer: A Case Report
review
OA: closed
CC0
⤵ 18 in-corpus citations
AI-generated summary
This case report describes ovarian endometrioid adenocarcinoma originating in an endometriotic cyst of a postmenopausal woman undergoing tamoxifen treatment for breast cancer.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
BackgroundOvarian cancer arising from an endometriotic cyst in a postmenopausal woman under tamoxifen therapy is rare.CaseWe herein report the case of a 67-year-old woman with a history of breast cancer, taking tamoxifen citrate 20 mg/day for 4 years, who underwent an operation for left ovarian tumor. The postoperative histological diagnosis was endometrioid adenocarcinoma in an endometriotic cyst with a gradual transition of the degree of cellular atypia noted from typical endometriotic epithelium, to atypical endometriosis, and finally to adenocarcinoma.ConclusionTamoxifen may cause malignant transformation of endometriosis through atypical endometriosis even in the postmenopausal state. Atypical endometriosis may act as a precancerous lesion in the process of tamoxifen-induced malignant transformation of endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (19)
- Benign, Borderline, and Malignant Endometrioid Neoplasia Arising in Endometriosis in Association with Tamoxifen Therapy via openalex
- <b>Ovarian atypical endometriosis: its close association with malignant epithelial tumours</b> via openalex
- <b>Tamoxifen‐associated post‐menopausal endometriosis</b> via openalex
- High Frequency of Adenomyosis in Postmenopausal Breast Cancer Patients Treated with Tamoxifen via openalex
- MALIGNANT TUMORS ARISING IN ENDOMETRIOSIS via openalex
- MALIGNANT TUMORS ARISING IN ENDOMETRIOSIS via openalex
- Ovarian Endometrioid Carcinoma and Endometriosis Developing in a Postmenopausal Breast Cancer Patient during Tamoxifen Therapy: A Case Report and Review of the Literature via openalex
- Ovarian Endometriosis Associated with Ovarian Carcinoma: A Clinicopathological and Immunohistochemical Study via openalex
- Ovarian tumors associated with atypical endometriosis via openalex
- W1557623912 via openalex
- W6633274885 via openalex
- W1965740586 via openalex
- W1970928234 via openalex
- W1979285649 via openalex
- W1984435323 via openalex
- W2038922688 via openalex
- W2087081961 via openalex
- W2412806217 via openalex
- W4322701966 via openalex
Cited by (18)
- Endometriosis in Menopausal Women-A New Age Is Coming? Literature Review 2024
- Atypical endometriosis: a review of an incompletely understood putative precursor of endometriosis-associated ovarian carcinoma 2023
- Malignant Transformation of Postmenopausal Endometriosis: A Systematic Review of the Literature 2021
- Asymptomatic Atypical Hyperplasia and Endometriosis Following Treatment with Tamoxifen: A Case Report and Review of the Literature 2020
- Endometriosis in Menopause—Renewed Attention on a Controversial Disease 2020
- Endométriose 2019
- Postmenopausal endometriosis, where are we now? 2019
- Three cases of clear‐cell adenocarcinoma arising from endometrioma during hormonal treatments 2018
- Postmenopausal endometriosis: drawing a clearer clinical picture 2018
- Concurrent tamoxifen-related Müllerian adenofibromas in uterus and ovary. 2015
- Endometriosis after Menopause 2015
- Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management 2009
- Co-Occurrence of Atypical Endometriosis, Subserous Uterine Leiomyomata, Sactosalpinx, Serous Cystadenoma and Bilateral Hemorrhagic Corpora Lutea in a Perimenopausal Adipose Patient Taking Tamoxifen (20 mg/Day) for Invasive Lobular Breast Cancer 2008
- Transformation maligne postménopausique d’une endométriose extragénitale. À propos d’un cas 2008
- Endometrioid adenocarcinoma of the ovary arising from endometriosis and presenting as an acute abdomen 2007
- Polypoid endometriosis and other benign gynaecological complications associated with Tamoxifen therapy—a case to illustrate features on magnetic resonance imaging 2006
- Malignant extraovarian endometriosis: A review 2005
- Adénocarcinome endométrioïde résultant de foyers d’adénomyose 2004
Source provenance
- europepmc
- last seen: 2026-10-04T09:26:46.659050+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:13:01.552487+00:00
- unpaywall
- last seen: 2026-10-04T06:29:23.997191+00:00
License: CC0
· commercial use OK